Amanta Healthcare Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- ✓Attractively valued vs sector (P/E 26.6x vs industry 54.4x)
Concerns
- ✗Trading near 52-week high (₹154)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
AMANTA · as of Jun 2026
| Category | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Promoters | 63.56% | 63.56% | 63.72% | 63.79% |
| FII | 1.00% | 1.10% | 0.85% | 0.43% |
| DII | 11.34% | 11.24% | 12.88% | 12.92% |
| Public | 24.10% | 24.09% | 22.55% | 22.84% |
Latest News
All news →Amanta Healthcare files routine insider trading disclosures
Amanta Healthcare has submitted disclosures under SEBI’s insider trading regulations. The filing is part of mandatory compliance requirements. No financial or operational updates were included. *No immediate market-moving implications.* 📊 *STOCKS:* AMANTAH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #Regulation
Amanta Healthcare files regulatory intimation under insider trading norms
*Amanta Healthcare files disclosure under SEBI insider trading regulations.* This is a routine compliance update pursuant to Regulation 7(2) of the Prohibition of Insider Trading norms. No financial or operational impact is indicated. **No material event** disclosed beyond regulatory requirements. 📊 *STOCKS:* AMANTAH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #Regulation
Amanta Healthcare files insider trading regulation update
Amanta Healthcare filed a disclosure under SEBI's insider trading regulations. The update is part of routine compliance requirements. No financial or operational details were provided. Such filings are standard and typically non-material. 📊 *STOCKS:* AMANTAHEALTH | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #Regulation
Amanta Healthcare files insider trading regulation update
*Amanta Healthcare files disclosure under SEBI insider trading norms.* This is a routine regulatory update under Regulation 7(2) of PIT Rules. No financial or operational impact indicated. **No material event** disclosed for investors. 📊 *STOCKS:* AMANTAHEALTH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #InsiderTrading
About Amanta Healthcare Limited
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products.[1]
Healthcare · Pharmaceuticals & Biotechnology